Linn Energy Is a Buy
Health Care: Health Services
GenMark Diagnostics Inc. (GNMK: NASDAQ)
$14.00 -0.54 | -3.71%
05/22/13 - 04:00 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 20.47M | 5.01M | 2.50M | 998.42K |
| Cost of Sales | 10.44M | 4.88M | 3.31M | 2.76M |
| Gross Operating Profit | 10.03M | 129.00K | -809.52K | -1.76M |
| Selling, General, and Administrative Expenses | 17.18M | 13.93M | 11.64M | 11.47M |
| Research & Development | 13.54M | 8.74M | 6.52M | 5.63M |
| Operating Income before D & A (EBITDA) | -20.69M | -22.54M | -18.97M | -18.87M |
| Depreciation & Amortization | 1.20M | 1.33M | 1.06M | 1.57M |
| Interest Income | 0.00 | 21.00K | 0.00 | 33.22K |
| Other Income - Net | -15.00K | 19.00K | 1.64M | 303.52K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -21.91M | -23.82M | -18.39M | -20.10M |
| Interest Expense | 49.00K | 95.00K | 582.00 | 0.00 |
| Pre-Tax Income | -21.96M | -23.92M | -18.39M | -20.10M |
| Income Taxes | 148.00K | 52.00K | 15.32K | -138.77K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -22.10M | -23.97M | -18.40M | -19.96M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -22.10M | -23.97M | -18.40M | -19.96M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -22.10M | -23.97M | -18.40M | -19.96M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-22.10M | -23.97M | -18.40M | -19.96M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -22.10M | -23.97M | -18.40M | -19.96M |
| Basic EPS from Continuing Ops. | -0.84 | -1.45 | -1.88 | -4.41 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.84 | -1.45 | -1.88 | -4.41 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.84 | -1.45 | -1.88 | -4.41 |
| Basic Normalized Net Income/Share | -0.84 | -1.45 | -1.88 | -4.41 |
| EPS fr Continuing Ops. | -0.84 | -1.45 | -1.88 | -4.41 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.84 | -1.45 | -1.88 | -4.41 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.84 | -1.45 | -1.88 | -4.41 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.84 | -1.45 | -1.88 | -4.41 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with GNMK
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBarron's Insider Purchases ...
Latest GNMK Headlines from TheStreet
- 4 Stocks Under $5 Making Big Up Moves 07.10.12 | 02:07 pm
- GenMark Diagnostics Inc. Stock Upgraded (GNMK) 06.29.12 | 05:06 am
- GenMark Diagnostics Inc. Stock Downgraded (GNMK) 11.23.11 | 06:11 am
- GenMark Diagnostics Inc. Stock Upgraded (GNMK) 08.26.11 | 07:08 am
- GenMark Diagnostics Inc. Stock Downgraded (GNMK) 08.11.11 | 07:08 am
- GenMark Diagnostics Inc. Stock Upgraded (GNMK) 08.09.11 | 07:08 am
- GenMark Diagnostics To Present At The Piper Jaffray 22nd Annual Health Care Conference 11.24.10 | 09:11 am
- GenMark Diagnostics To Present At William Blair Emerging Growth Stock Conference 10.01.10 | 07:10 am
- GenMark IPO Better than Mirion IPO
05.25.10 | 06:05 am
Press Releases for GNMK
- GenMark Diagnostics Reports Fourth Quarter And Year End 2012 Results - Business Wire 03.12.13 | 04:03 pm
- GenMark Diagnostics Schedules Fourth Quarter And Full Year 2012 Financial Results And Conference Call For March 12, 2013 - Business Wire 02.28.13 | 05:02 pm
- GenMark Diagnostics To Present At The 31st Annual J.P. Morgan Healthcare Conference - Business Wire 01.04.13 | 04:01 pm
- GenMark Diagnostics To Present At The Canaccord Genuity Medical Technology & Diagnostics Forum - Business Wire 11.26.12 | 09:11 am
- GenMark Diagnostics To Present At The Piper Jaffray 24th Annual Healthcare Conference - Business Wire 11.20.12 | 06:11 pm
- GenMark Diagnostics Reports Third Quarter 2012 Results - Business Wire 11.07.12 | 06:11 pm
- GenMark Diagnostics Schedules Third Quarter 2012 Financial Results And Conference Call For November 8, 2012 - Business Wire 10.26.12 | 02:10 pm
- GenMark To Show Its All-Electronic, Sample-to-Answer Molecular Diagnostics Platform At The Association For Molecular Pathology Meeting - Business Wire 10.22.12 | 09:10 am
- GenMark Diagnostics Receives FDA Clearance For RVP Test - Business Wire 09.12.12 | 09:09 am
- GenMark Diagnostics To Present At Canaccord Genuity 32nd Annual Growth Conference - Business Wire 08.15.12 | 09:08 am
Partner Headlines for GNMK
- FDA Clears GenMark's Newest Test - Analyst Blog - NASDAQ 09.13.12 | 04:09 pm
- Weekly CFO Buys Highlight: XPL, GNMK - GuruFocus 07.02.12 | 12:07 pm
- Weekly CEO Buys Highlight: SXL, JBSS, GNMK, CNDO, DCO - GuruFocus 06.30.12 | 02:06 pm
- GenMark Diagnostics Appoints Richard B. Slansky Chief Financial Officer - Benzinga 04.02.12 | 04:04 pm
- After Shaky August, IPO Market Attempts To Right Itself - Seeking Alpha 09.23.11 | 08:09 am
- 10 Rallying Small-Caps Bought Up By Insiders - Seeking Alpha 09.16.11 | 04:09 pm
- 2010 Year-End U.S. IPO Review and 2011 Outlook - Seeking Alpha 03.04.11 | 02:03 pm
- William Blair & Co. Initiates Outperform Rating on GenMark Diagnostics (GNMK) - Benzinga 07.12.10 | 09:07 am
